Mary Spellman, MD
Castle Creek Pharmaceuticals
2
0
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Mary Spellman
Castle Creek Pharmaceuticals, LLC
Shared therapeutic areas:
Worked with same sponsors:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Alexandra DJ Mancini, MSc
InMed Pharmaceuticals Inc.
Shared therapeutic areas:
Amy S Paller, MD
Northwestern University
Shared therapeutic areas:
Sarah Chaumon
Assistance Publique - Hôpitaux de Paris
Shared therapeutic areas:
Christine Chiaverini, PH
Centre Hospitalier Universitaire de Nice
Shared therapeutic areas:
Joyce M Teng, MD, PhD
Stanford School of Medicine
Shared therapeutic areas:
Elena Pope, MD
The Hospital for Sick Children
Shared therapeutic areas:
Nashwa K Radwan, PhD
NATIONAL CENTER FOR RADIATION RESEARCH AND TECHNOLOGY
Shared therapeutic areas:
John E. Wagner, MD
Masonic Cancer Center, University of Minnesota
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
Safety and Efficacy of Diacerein 1% Ointment for Subjects With Epidermolysis Bullosa Simplex (EBS)
All 2 trials loaded